Validated for Global Scale: DIAGNOS Passes Annual MDSAP Audit, Solidifying the Pathway to Approvals with Health Canada & FDA

Stock Information for Diagnos Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Diagnos Inc.

Diagnos Announces Closing of Oversubscribed $4 Million Brokered Private Placement Led by Centurion One Capital
Diagnos Announces Upsize of Previously Announced Brokered Private Placement to $3.65M Led by Centurion One Capital
DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on December 5, 2025
DIAGNOS Announces $2.0 Million Brokered Private Placement Led by Centurion One Capital
DIAGNOS Strengthens Governance and Leadership with the Appointment of Philippe Couillard as Chairman of the Board of Directors
DIAGNOS Welcomes Dr. Pierre-Luc Charlebois to its Advisory Board
DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on November 9, 2025
DIAGNOS to Present at the Centurion One Capital 3rd Annual Bahamas Summit

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.